Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial

Martin G. Sauer; Peter J. Lang; Michael H. Albert; Peter Bader; Ursula Creutzig; Matthias Eyrich; Johann Greil; Bernd Gruhn; Wolfgang Holter; Thomas Klingebiel; Bernhard Kremens; Heiko von der Leyen; Christine Mauz-K?rholz; Roland Meisel; Kirsten Mischke; Ingo Müller; Charlotte M. Niemeyer; Christina Peters; Christine Pohler; Dirk Reinhardt; Birgit Burkhardt; Paul G. Schlegel; Ansgar S. Schulz; Johanna Schrum; Petr Sedlacek; Brigitte Strahm; Wilhelm Woessmann; Rupert Handgretinger; Martin Zimmermann; Arndt Borkhardt

首页> 外文期刊>Leukemia >Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial

【24h】

Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial

机译：矫正：急性骨髓白血病儿童的造血干细胞移植 - AML SCT-BFM 2007试验的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

机译：发布了对本文的修正，并可通过本文顶部的链接访问。

著录项

来源
《Leukemia》 |2020年第5期|共1页
作者
Martin G. Sauer; Peter J. Lang; Michael H. Albert; Peter Bader; Ursula Creutzig; Matthias Eyrich; Johann Greil; Bernd Gruhn; Wolfgang Holter; Thomas Klingebiel; Bernhard Kremens; Heiko von der Leyen; Christine Mauz-K?rholz; Roland Meisel; Kirsten Mischke; Ingo Müller; Charlotte M. Niemeyer; Christina Peters; Christine Pohler; Dirk Reinhardt; Birgit Burkhardt; Paul G. Schlegel; Ansgar S. Schulz; Johanna Schrum; Petr Sedlacek; Brigitte Strahm; Wilhelm Woessmann; Rupert Handgretinger; Martin Zimmermann; Arndt Borkhardt;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial [J] . Hyakuna Nobuyuki, Hashii Yoshiko, Ishida Hiroyuki, Pediatric blood & cancer . 2019,第10期

机译：高风险急性髓性白血病儿童的回顾性分析，在AML-05临床试验中完全缓解后异构造血干细胞移植进行异种造血干细胞移植
2. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. [J] . Schlenk RF, Dohner K, Mack S, Journal of Clinical Oncology . 2010,第30期

机译：对匹配的相关和匹配的不相关供体进行同种异体造血干细胞移植的前瞻性评估：患有高风险急性髓性白血病的年轻人：德国-奥地利试验AMLHD98A。
3. Transplant Rates and Outcomes of Young Acute Myeloid Leukemia (AML) Patients with Intermediate and Poor Risk Disease Referred to a Coordinated Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Program [J] . Solh Melhem, Zhang Xu, Bashey Asad, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：患有中间骨髓性白血病（AML）患者的移植率和结果患者中间体和贫困性疾病的患者提到了协调急性白血病和造血干细胞移植（HSCT）方案
4. Adhesion of Hematopoietic Stem Cells and Acute Myeloid Leukemia Cell Lines to Functionalized Surfaces of P-Selectin and Cd34 Antibody [C] . Michael R. King, Jane L. Liesveld, Nichola Charles International Symposium on Runaway Reactions, Pressure Relief Design and Effluent Handling American Institute of Chemical Engineers/American Chemical Society Management Conference . 2005

机译：造血干细胞的粘附和急性髓性白血病细胞系对P-Selectin和CD34抗体的官能化表面
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-Identical Peripheral Blood Hematopoietic Stem Cell Transplantation [O] . Nan Yang, Lixun Guan, Zhanxiang Liu, 2019

机译：ABO血型不相容性不是未经操作的单倍相同外周血造血干细胞移植后急性髓细胞性白血病（AML）患者结果的危险因素
7. Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548) [O] . Schroeder T., Czibere A.G., Kröger N., 2011

机译：将阿扎胞苷（Vidaza®，Aza）和供体淋巴细胞输注（DLI）结合作为异基因造血干细胞移植（allo-SCT）复发的急性髓样白血病（AML）或骨髓增生异常综合征（MDS）复发的患者（PTS）的首次抢救治疗： Azarela试用版的中期分析（NCT-00795548）

Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial

摘要

著录项

相似文献

相关主题

期刊订阅